Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population.
Microglia-derived IL-1β triggers p53-mediated cell cycle arrest and apoptosis in neural precursor cells.
[Actual medical care situation and therapeutic needs in multiple sclerosis : Impact of the Pharmaceutical Market Restructuring Act (AMNOG)].
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
Unilateral internuclear ophthalmoplegia after minor head injury.
Multiple Sclerosis.
Personality factors in recently diagnosed multiple sclerosis patients: a preliminary investigation with the NEO-FFI scale.
Is there a (host) genetic predisposition to progressive multifocal leukoencephalopathy?
Preclinical Models of Multiple Sclerosis: Advantages and Limitations towards Better Therapies.
Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS.
Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?
The natural dual cyclooxygenase and 5-lipoxygenase inhibitor flavocoxid is protective in EAE through effects on Th1/Th17 differentiation and macrophage/microglia activation.
Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI.
Chronic inflammatory demyelinating polyneuropathy in common variable immunodeficiency.
Response to Comment on "Thiamine Deficiency Promotes T Cell Infiltration in Experimental Autoimmune Encephalomyelitis: The Involvement of CCL2".
Cost Offset Analysis of Interferon Beta Disease Modifying Therapies In Relapsing-Remitting Multiple Sclerosis.
Ethanol-Induced TLR4/NLRP3 Neuroinflammatory Response in Microglial Cells Promotes Leukocyte Infiltration Across the BBB.
Increased serum levels of C21 steroids in female patients with multiple sclerosis.
Efficacy of Schwann Cell (SC) transplantation for spinal cord repair is improved with combinatorial strategies.
Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment.
12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis.
HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.
Optical coherence tomography in the diagnosis and management of optic neuritis and multiple sclerosis.
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.
Pages
« first
‹ previous
…
709
710
711
712
713
714
715
716
717
…
next ›
last »